California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant. Cognixion is one of several ...

Synchron's Stentrode is implanted within the blood vessels of the brain via a catheter, with the goal of avoiding open surgery. (Synchron) The brain-computer interface developer Synchron has shown ...

Cognixion, a developer of noninvasive brain-computer interface technology, has launched a clinical study that integrates its EEG-based brain-computer interface with Apple Vision Pro. The study aims to ...

A new brain implant now lets people control Apple devices, such as iPads, iPhones and the Vision Pro, using only their thoughts. Synchron, an endovascular brain-computer interface (BCI) company based ...

Apple has recently secured a patent for a neural interface technology that promises to revolutionize how users interact with their devices. By leveraging brain-computer interface (BCI) technology, ...

Synchron, the brain-computer interface company whose Stentrode implant reaches the brain through a blood vessel instead of ...

A new study may ultimately help stroke sufferers, plus people with ALS, spinal cord injury, and more, be able to use Apple Vision Pro to help them communicate without needing invasive surgery first.

On this episode of Uncanny Valley, we dive into the heated race between two companies to build a commercial brain-computer interface. Brain-computer interfaces might have inspired works of science ...

Forbes contributors publish independent expert analyses and insights. I write about the big picture of artificial intelligence. We stand at the cusp of a massive technology paradigm shift that ...